Clinical trial
Observational Endothelin and Markers of Cellular Apoptosis In CSF Head Injury
NCT00498498 · Virginia Commonwealth University, Other · Completed
Key facts
| NCT number | NCT00498498 |
|---|---|
| Title | Observational Endothelin and Markers of Cellular Apoptosis In CSF Head Injury |
| Official title | A Multicenter Observational Study to Evaluate Dynamics of Endothelin and Markers of Cellular Apoptosis in Cerebrospinal Fluid and Plasma in Moderate and Severe Human Head Injury |
| Acronym | Endothelin |
| Lead sponsor | Virginia Commonwealth University, Other |
| Collaborators | Solvay Pharmaceuticals Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Cerebrovascular Trauma, Neurohormones, Cellular Apoptosis, Endothelin System |
| Enrollment | 51 |
| Start date | Jul 1, 2007 |
| Primary completion | Jun 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jul 10, 2007 |
| Last update posted | Nov 16, 2011 |
| Countries | Germany, Italy, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: